|
|
||||||||||
|
J Am Coll Cardiol, 2000; 36:739-745 © 2000 by the American College of Cardiology Foundation |


a Nuclear Medicine Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
* Division of Cardiology, Careggi Hospital, Florence, Italy
Nuclear Medicine, University of Turin, Turin, Italy
Manuscript received October 21, 1999; revised manuscript received March 15, 2000, accepted April 26, 2000.
Reprint requests and correspondence: Dr. Roberto Sciagrà, Nuclear Medicine Unit, Department of Clinical Physiopathology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
r.sciagra{at}dfc.unifi.it
OBJECTIVES
The aim of the study was to verify the prognostic implications of viability detection using baseline-nitrate sestamibi imaging in patients with left ventricular (LV) dysfunction due to chronic coronary artery disease (CAD) submitted to different therapeutic strategies.
BACKGROUND
The prognostic meaning of preserved viability in these patients is still debated. Sestamibi is increasingly used for myocardial perfusion scintigraphy and is being accepted also as viability tracer, but no data are available about the relationship between viability in sestamibi imaging, subsequent treatment, and patients outcome.
METHODS
Follow-up data were collected in 105 CAD patients with LV dysfunction who had undergone baseline-nitrate sestamibi perfusion imaging for viability assessment and had been later treated medically (group 1), or submitted to revascularization, which was either complete (group 2A) or incomplete (group 2B).
RESULTS
Eighteen hard events (cardiac death or nonfatal myocardial infarction) were registered during the follow-up. A significantly worse event-free survival curve was observed in the patients of group 1 (p < 0.0002) and group 2B (p < 0.03) compared to those of group 2A. Using a Cox proportional hazard model, the most powerful prognostic predictors of events were the number of nonrevascularized asynergic segments with viability in sestamibi imaging (p < 0.003, risk ratio [RR] = 1.4), and the severity of CAD (p < 0.02, RR = 1.28).
CONCLUSIONS
Viability detection in sestamibi imaging has important prognostic implications in CAD patients with LV dysfunction. Patients with preserved viability kept on medical therapy or submitted to incomplete revascularization represent high-risk groups.
| ||||||||||||||||||||||||
This article has been cited by other articles:
![]() |
P. G. Camici, S. K. Prasad, and O. E. Rimoldi Stunning, Hibernation, and Assessment of Myocardial Viability Circulation, January 1, 2008; 117(1): 103 - 114. [Full Text] [PDF] |
||||
![]() |
A. F.L. Schinkel, D. Poldermans, A. Elhendy, and J. J. Bax Assessment of Myocardial Viability in Patients with Heart Failure J. Nucl. Med., July 1, 2007; 48(7): 1135 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H.J.A. Slart, A. Agool, D. J. van Veldhuisen, R. A. Dierckx, and J. J. Bax Nitrate Administration Increases Blood Flow in Dysfunctional but Viable Myocardium, Leading to Improved Assessment of Myocardial Viability: A PET Study J. Nucl. Med., August 1, 2006; 47(8): 1307 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zimarino, A. M. Calafiore, and R. De Caterina Complete myocardial revascularization: between myth and reality Eur. Heart J., September 2, 2005; 26(18): 1824 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giorgetti, A. Pingitore, B. Favilli, A. Kusch, M. Lombardi, and P. Marzullo Baseline/Postnitrate Tetrofosmin SPECT for Myocardial Viability Assessment in Patients with Postischemic Severe Left Ventricular Dysfunction: New Evidence from MRI J. Nucl. Med., August 1, 2005; 46(8): 1285 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J J Bax, E E van der Wall, and M Harbinson Radionuclide techniques for the assessment of myocardial viability and hibernation Heart, August 1, 2004; 90(suppl_5): v26 - v33. [Full Text] [PDF] |
||||
![]() |
J.S. Billing, A. Ooi, and S. R. Large The outcome of cardiac surgery in high-risk quaternary referral patients Interactive CardioVascular and Thoracic Surgery, September 1, 2003; 2(3): 369 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tadamura, M. Mamede, S. Kubo, H. Toyoda, M. Yamamuro, H. Iida, N. Tamaki, K. Nishimura, M. Komeda, and J. Konishi The Effect of Nitroglycerin on Myocardial Blood Flow in Various Segments Characterized by Rest-Redistribution Thallium SPECT J. Nucl. Med., May 1, 2003; 44(5): 745 - 751. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |